Advertisement
U.S. Markets closed

Perspective Therapeutics, Inc. (CATX)

NYSE American - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
11.53-0.36 (-3.03%)
At close: 04:00PM EDT
12.10 +0.57 (+4.94%)
After hours: 06:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 777.44M
Enterprise Value 488.45M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.28
Enterprise Value/Revenue 68.73
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.44
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.10
52 Week Low 32.20
50-Day Moving Average 313.72
200-Day Moving Average 312.42

Share Statistics

Avg Vol (3 month) 3862.53k
Avg Vol (10 day) 3721.37k
Shares Outstanding 567.43M
Implied Shares Outstanding 6N/A
Float 843.36M
% Held by Insiders 120.43%
% Held by Institutions 160.62%
Shares Short (Sep 30, 2024) 49.59M
Short Ratio (Sep 30, 2024) 48.97
Short % of Float (Sep 30, 2024) 417.32%
Short % of Shares Outstanding (Sep 30, 2024) 414.22%
Shares Short (prior month Aug 30, 2024) 46.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,711.60%

Management Effectiveness

Return on Assets (ttm)-12.03%
Return on Equity (ttm)-23.20%

Income Statement

Revenue (ttm)1.46M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-10.50%
Gross Profit (ttm)N/A
EBITDA -47.27M
Net Income Avi to Common (ttm)-52.16M
Diluted EPS (ttm)-1.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)292.87M
Total Cash Per Share (mrq)4.34
Total Debt (mrq)3.88M
Total Debt/Equity (mrq)1.14
Current Ratio (mrq)27.73
Book Value Per Share (mrq)5.06

Cash Flow Statement

Operating Cash Flow (ttm)-14.17M
Levered Free Cash Flow (ttm)-33.29M